Inspire Medical Systems, Inc. (INSP) stock
INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 17/3029% below fair value
$61.10+0.56 (+0.93%)
Close on Nov 13, 2026Market cap $1.77BP/E 17.8Yield –
Inspire Medical Systems ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Inspire Medical Systems's ebitda for the twelve months ending Sep 30, 2026 was $34.40M, down 30.3% year over year. For fiscal 2025 it was $64.91M, up 52.3% from the year before. The highest annual figure on record is $64.91M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.91M | +52.3% |
| FY2024 | Dec 31, 2024 | $42.63M | – |
| FY2023 | Dec 31, 2023 | -$37.43M | – |
| FY2022 | Dec 31, 2022 | -$45.73M | – |
| FY2021 | Dec 31, 2021 | -$38.63M | – |
| FY2020 | Dec 31, 2020 | -$55.37M | – |
| FY2019 | Dec 31, 2019 | -$34.40M | – |
| FY2018 | Dec 31, 2018 | -$19.99M | – |
| FY2017 | Dec 31, 2017 | -$15.72M | – |
| FY2016 | Dec 31, 2016 | -$17.15M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$23.62M | -277.0% |
| Q2 FY2026 | Jun 30, 2026 | $4.09M | +4764.3% |
| Q1 FY2026 | Mar 31, 2026 | $3.99M | +156.1% |
| Q4 FY2025 | Dec 31, 2025 | $49.93M | +45.3% |
| Q3 FY2025 | Sep 30, 2025 | $13.34M | -17.7% |
| Q2 FY2025 | Jun 30, 2025 | $84.00K | -98.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.56M | – |
| Q4 FY2024 | Dec 31, 2024 | $34.36M | +239.7% |
| Q3 FY2024 | Sep 30, 2024 | $16.22M | – |
| Q2 FY2024 | Jun 30, 2024 | $6.50M | – |
| Q1 FY2024 | Mar 31, 2024 | -$14.38M | – |
| Q4 FY2023 | Dec 31, 2023 | $10.11M | +4222.2% |
| Q3 FY2023 | Sep 30, 2023 | -$12.67M | – |
| Q2 FY2023 | Jun 30, 2023 | -$15.90M | – |
| Q1 FY2023 | Mar 31, 2023 | -$18.91M | – |
| Q4 FY2022 | Dec 31, 2022 | $234.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$16.69M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.61M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.70M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.48M | – |
| Q3 FY2021 | Sep 30, 2021 | -$9.50M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.24M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.46M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.81M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.69M | – |
| Q2 FY2020 | Jun 30, 2020 | -$22.61M | – |
| Q1 FY2020 | Mar 31, 2020 | -$16.25M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.14M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.55M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.08M | – |
| Q1 FY2019 | Mar 31, 2019 | -$8.67M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.79M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.55M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.54M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.11M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.74M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.55M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.33M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.08M | – |
See a number that looks wrong?